World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 October 2016
Main ID:  ISRCTN19321911
Date of registration: 27/03/2009
Prospective Registration: Yes
Primary sponsor: Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Public title: Surgical Trial In Traumatic intraCerebral Haemorrhage
Scientific title: Surgical Trial In Traumatic intraCerebral Haemorrhage: an international multi-centre pragmatic randomised parallel group trial
Date of first enrolment: 01/09/2009
Target sample size: 840
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN19321911
Study type:  Interventional
Study design:  International multi-centre pragmatic randomised parallel-group trial (Treatment)  
Phase: 
Countries of recruitment
Czech Republic Egypt Germany Greece India Italy Latvia Lithuania
Macedonia Poland Russian Federation Spain United Kingdom United States of America
Contacts
Name: Barbara A    Gregson
Address:  Neurosurgical Trials Unit Newcastle University 3-4 Claremont Terrace NE2 4AE Newcastle upon Tyne United Kingdom
Telephone: -
Email: trauma.stitch@ncl.ac.uk
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Both males and females, adults aged 14 or over
2. Evidence of a traumatic intracerebral haemorrhage (TICH) on computed tomography (CT) with a single volume of attenuation significantly raised above that of the background white and grey matter that is in total greater than 10 ml calculated by width times height times length in cm divided by 2
3. Within 24 hours of head injury
4. Clinical equipoise: only patients for whom the responsible neurosurgeon is uncertain about the benefits of either treatment are eligible

Exclusion criteria: 1. A significant surface haematoma (epidural haematoma [EDH] or subdural haematoma [SDH]) requiring surgery (The indications for intervention for these patients are already very well defined)
2. More than two separate haematomas fulfilling inclusion criteria
3. If surgery can not be performed within 36 hours of injury or 12 hours of randomisation (whichever is the shorter)
4. Severe pre-existing physical or mental disability or severe co-morbidity which might lead to a poor outcome even if the patient made a full recovery from the head injury (Examples would be a high level of dependence before the injury or severe irreversible associated injury such as complete spinal cord injury)
5. Permanent residence outside a study country preventing follow up
6. Patient and/or relative has a strong preference for one treatment modality


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Traumatic intracerebral haemorrhage and contusion
Injury, Occupational Diseases, Poisoning
Intracerebral haemorrhage
Intervention(s)
Early surgery vs initial conservative treatment
Primary Outcome(s)
Unfavourable outcome will be death or severe disability which will be defined using a prognosis based 8 point Glasgow Outcome Scale.

Total duration of follow-up: 6 months
Secondary Outcome(s)
The following will be assessed at 6 and 12 months:
1. Rankin scale
2. Euroqol EQ-5D
3. Mortality
4. Survival
5. Major Adverse Events (death, pulmonary embolism or deep vein thrombosis, infection, rehaemorrhage)
6. Quality-adjusted life-years (QALYs)
7. Total health care costs
8. Social costs
Secondary ID(s)
HTA 07/37/16; 1.0
Source(s) of Monetary Support
Health Technology Assessment Programme
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history